Guzman Y GOMEZ Ltd (GYG)
Australian Securities Exchange · Australia · prices in AUD · close of 22 Oct 2026
Key indicators
| Last close | AUD 25.50 |
|---|---|
| 52-week range | 15.06 – 30.11 |
| Return, 1 month / 3 months | −0.4% / +16.7% |
| Return, 1 year / 3 years | +4.1% / – |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 44 |
| Volatility (1 year) | 51.8% |
| Worst drawdown (1 year) | -42.9% |
| Average daily value traded | 10.28M AUD |
| Dividend yield | 1.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Guzman y Gomez is an Australian restaurant chain serving Mexican-style food. Its menu centres on burritos, tacos, nachos, quesadillas and bowls, along with sides and drinks, prepared to order. The company runs its own restaurants and works with franchise partners, serving customers in Australia and in selected overseas markets. It is based in Australia and appeals to people looking for quick, casual meals in a lively setting.
On this site Guzman Y GOMEZ Ltd appears as a stock on the Australian Securities Exchange (Australia), code GYG, with prices in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Guzman Y GOMEZ Ltd (GYG) trades on the Australian Securities Exchange in Australia. It last closed at AUD 25.50 on 22 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 219 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 4.1% and over the last three months it rose 16.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 91 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 19.5% | ||
| From 52-week high | -15.2% | ||
| Momentum | 83 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 16.7% | ||
| 6-month return | 30.1% | ||
| 12-month return, skipping the last month | 4.5% | ||
| Stability (higher is calmer) | 69 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 51.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -42.9% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 10.28M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 11 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.9% | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −4.9% |
|---|---|
| 1 month | −0.4% |
| 3 months | +16.7% |
| 6 months | +30.1% |
| 1 year | +4.1% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 26.13 / 21.34 |
|---|---|
| Golden / death cross (60 days) | Golden, 58 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.99 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Sep 2026 | AUD 0.4060 |
| 13 Mar 2026 | AUD 0.0740 |
| 15 Sep 2025 | AUD 0.1260 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.